David Michael Johnson, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 17,000 shares at $9.88 ($168K) on 2023-11-10, disclosed to the SEC on 2023-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2023-01-09 | $21K | — | Filing → |
| AURA | BUY | 2022-12-30 | $20K | — | Filing → |